• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索沙特阿拉伯药学成果与政策研究哲学博士项目的价值。

Exploring the value of a Doctor of Philosophy program in Pharmaceutical Outcomes and Policy Research in Saudi Arabia.

作者信息

AlRuthia Yazed, Al-Washali Nasser Yahya, Aljuhani Raneem, Sales Ibrahim, Balkhi Bander, Alghaiheb Abdlatif, Arafah Azher, Almalag Haya M, Alsultan Abdullah, Alqahtani Saeed A, Alwhaibi Monira

机构信息

Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.

出版信息

Saudi Pharm J. 2020 Jan;28(1):107-115. doi: 10.1016/j.jsps.2019.11.012. Epub 2019 Dec 6.

DOI:10.1016/j.jsps.2019.11.012
PMID:31920437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6950942/
Abstract

BACKGROUND

The need for graduate education in Pharmaceutical Outcomes and Policy Research (POPR) is becoming increasingly apparent worldwide. However, the number of professionals in this field is inadequate in the Middle East. Therefore, this study aimed at gaining insight into the perceived value of a potential Doctor of Philosophy (Ph.D.) program in POPR among different stakeholders in Saudi Arabia.

METHODS

Following the development of a Ph.D. program structure in POPR, a questionnaire was created to explore the perception of its value among decision-makers in different healthcare and governmental institutions. An email with detailed information on the proposed program was sent to 131 identified individuals along with an online link to the questionnaire.

RESULTS

Responses were provided by 107 (81.67%) individuals. The majority of respondents (53.3%) represented large organizations with more than 500 workers; hospitals and academia were the most represented types of institutions. More than 85% of the participants strongly agreed that the program will meet the needs of the healthcare market in Saudi Arabia and that there will be a demand for graduates of the program over the next 5-10 years. However, only 28.04% of the participants declared that they would definitely recommend the program to their colleagues and employees, and 49.53% would consider employing its graduates.

CONCLUSIONS

The obtained results indicate a significant interest among different stakeholders in introducing a Ph.D. program in POPR in Saudi Arabia.

摘要

背景

全球范围内,药物结果与政策研究(POPR)领域对研究生教育的需求日益明显。然而,中东地区该领域的专业人员数量不足。因此,本研究旨在深入了解沙特阿拉伯不同利益相关者对POPR领域潜在哲学博士(Ph.D.)项目价值的看法。

方法

在制定POPR领域的博士项目结构后,设计了一份问卷,以探究不同医疗保健和政府机构决策者对其价值的看法。一封包含该项目详细信息的电子邮件被发送给131名确定的个人,并附上问卷的在线链接。

结果

107名(81.67%)个人提供了回复。大多数受访者(53.3%)来自拥有500多名员工的大型组织;医院和学术界是代表性最强的机构类型。超过85%的参与者强烈认为该项目将满足沙特阿拉伯医疗保健市场的需求,并且在未来5至10年内对该项目的毕业生有需求。然而,只有28.04%的参与者表示肯定会向同事和员工推荐该项目,49.53%的参与者会考虑聘用该项目的毕业生。

结论

所获结果表明,沙特阿拉伯不同利益相关者对引入POPR领域的博士项目有着浓厚兴趣。

相似文献

1
Exploring the value of a Doctor of Philosophy program in Pharmaceutical Outcomes and Policy Research in Saudi Arabia.探索沙特阿拉伯药学成果与政策研究哲学博士项目的价值。
Saudi Pharm J. 2020 Jan;28(1):107-115. doi: 10.1016/j.jsps.2019.11.012. Epub 2019 Dec 6.
2
Competency assessment in laboratory medicine: Standardization and utility for technical staff assessment and recertification in Saudi Arabia.沙特阿拉伯的实验室医学能力评估:技术人员评估和再认证的标准化和实用性。
Med Teach. 2017 Apr;39(sup1):S63-S74. doi: 10.1080/0142159X.2016.1254751. Epub 2017 Feb 5.
3
Public health education in Saudi Arabia: Needs and challenges.沙特阿拉伯的公共卫生教育:需求与挑战。
Med Teach. 2016;38 Suppl 1:S5-8. doi: 10.3109/0142159X.2016.1142514.
4
Perception and attitude of healthcare workers in Saudi Arabia with regard to Covid-19 pandemic and potential associated predictors.沙特阿拉伯医护人员对新冠疫情的认知和态度,以及潜在的相关预测因素。
BMC Infect Dis. 2020 Sep 29;20(1):719. doi: 10.1186/s12879-020-05443-3.
5
Questionnaire-based analysis of infection prevention and control in healthcare facilities in Saudi Arabia in regards to Middle East Respiratory Syndrome.基于问卷调查对沙特阿拉伯医疗机构中东呼吸综合征感染预防与控制情况的分析
J Infect Public Health. 2017 Sep-Oct;10(5):548-563. doi: 10.1016/j.jiph.2016.11.008. Epub 2017 Feb 16.
6
Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia.沙特阿拉伯医院医护人员对药物警戒的认知与态度。
Int J Clin Pharm. 2015 Dec;37(6):1104-10. doi: 10.1007/s11096-015-0165-5. Epub 2015 Jul 28.
7
Predictors of success for Saudi Arabian students enrolled in an accelerated baccalaureate degree program in nursing in the United States.在美国参加护理学加速学士学位课程的沙特阿拉伯学生成功的预测因素。
J Prof Nurs. 2007 Sep-Oct;23(5):301-8. doi: 10.1016/j.profnurs.2007.06.001.
8
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
9
Current status and vision of local pharmaceutical industries in Saudi Arabia: The focus on nanomedicines.沙特阿拉伯当地制药行业的现状与展望:聚焦纳米药物
Saudi Pharm J. 2023 Aug;31(8):101674. doi: 10.1016/j.jsps.2023.06.007. Epub 2023 Jun 16.
10
Preferences on Policy Options for Ensuring the Financial Sustainability of Healthcare Services in the Kingdom of Saudi Arabia.沙特阿拉伯王国确保医疗服务财务可持续性的政策选项偏好
Risk Manag Healthc Policy. 2023 Jun 12;16:1033-1047. doi: 10.2147/RMHP.S414823. eCollection 2023.

本文引用的文献

1
Drug shortages in Saudi Arabia: Root causes and recommendations.沙特阿拉伯的药品短缺:根本原因与建议。
Saudi Pharm J. 2018 Nov;26(7):947-951. doi: 10.1016/j.jsps.2018.05.002. Epub 2018 May 12.
2
The status of licensed pharmacy workforce in Saudi Arabia: a 2030 economic vision perspective.沙特阿拉伯持照药剂师劳动力状况:2030 年经济展望视角。
Hum Resour Health. 2018 Jun 28;16(1):28. doi: 10.1186/s12960-018-0294-8.
3
Further Steps in the Development of Pharmacoeconomics, Outcomes Research, and Health Technology Assessment in Central and Eastern Europe, Western Asia, and Africa.
Value Health Reg Issues. 2013 Sep-Oct;2(2):169-170. doi: 10.1016/j.vhri.2013.07.007. Epub 2013 Sep 13.
4
PHARMACOECONOMIC STUDIES IN WORLD HEALTH ORGANIZATION EASTERN MEDITERRANEAN COUNTRIES: REPORTING COMPLETENESS.世界卫生组织东地中海国家的药物经济学研究:报告完整性。
Int J Technol Assess Health Care. 2017 Jan;33(2):215-221. doi: 10.1017/S026646231700037X. Epub 2017 Jun 5.
5
Pharmacoeconomics education in US colleges and schools of pharmacy.美国药学院校的药物经济学教育。
Am J Pharm Educ. 2013 Sep 12;77(7):145. doi: 10.5688/ajpe777145.
6
Pharmacoeconomic education in Egyptian schools of pharmacy.埃及药学院校的药物经济学教育。
Am J Pharm Educ. 2013 Apr 12;77(3):57. doi: 10.5688/ajpe77357.
7
Assessing the quality of pharmacoeconomic studies in India: a systematic review.评估印度药物经济学研究的质量:一项系统评价。
Pharmacoeconomics. 2012 Sep 1;30(9):749-62. doi: 10.2165/11590140-000000000-00000.
8
Pharmacoeconomics and outcomes research degree-granting PhD programs in the United States.美国的药物经济学和结果研究博士学位课程。
Res Social Adm Pharm. 2013 Jan-Feb;9(1):108-13. doi: 10.1016/j.sapharm.2012.03.002. Epub 2012 May 2.
9
Pharmacoeconomic education in US colleges and schools of pharmacy: an update.美国药学院校的药物经济学教育:最新情况
Am J Pharm Educ. 2008 Jun 15;72(3):51. doi: 10.5688/aj720351.
10
Pharmacoepidemiology education in US colleges and schools of pharmacy.美国药学院校的药物流行病学教育
Am J Pharm Educ. 2007 Aug 15;71(4):80. doi: 10.5688/aj710480.